The short fiber knobs of human adenovirus in species F elicit cross-neutralizing antibody responses

被引:1
|
作者
Liu, Zhenwei [1 ,2 ,3 ]
Tang, Guolu [1 ,2 ]
Peng, Yinghui [1 ,2 ]
Lan, Jixian [4 ]
Xian, Yuting [4 ]
Tian, Xingui [3 ]
Chen, Dehui [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, State Key Lab Resp Dis, Guangdong Hong Kong Macao Joint Lab Resp Infect Di, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China
[4] Guangdong Sanmai Biotechnol Co Ltd, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Human adenovirus type 40 and 41; Short fiber knob; Cross-neutralization; MOLECULAR CHARACTERIZATION; ACUTE GASTROENTERITIS; CHILDREN; IDENTIFICATION; RECEPTOR; TRANSMISSION; DIARRHEA; VECTORS; HEXON; AGE;
D O I
10.1016/j.heliyon.2024.e35783
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human adenovirus (HAdV) type 40 in species F (HAdV-F40) and HAdV-F41 represent the third most prevalent causative agents of non-bacterial acute gastroenteritis in infants and young children, following norovirus and rotavirus. Despite their significant contribution to global child morbidity, vaccines to preemptively combat these viruses remain elusive. In this study, we investigate the potential for cross-neutralization between HAdV-F40 and HAdV-F41 using immune sera with the short fiber knob (SFK). We implemented a series of assays to evaluate the responses, including enzyme-linked immunosorbent, micro-neutralization, immunofluorescence, and quantitative polymerase chain reaction. Our results demonstrate that immune sera with HAdV-F40 SFK or HAdV-F41 SFK could effectively neutralize both HAdV-F40 and HAdV-F41, indicating a mutual cross-neutralizing effect. Notably, the immune sera with HAdV-F40 SFK demonstrated a stronger neutralization effect, suggesting the potential to develop a subunit vaccine that can simultaneously counteract both viruses. These findings underscore the potential of SFK immunization in evoking a cross-neutralizing antibody response between HAdV-F40 and HAdV-F41. This suggests a promising avenue for developing subunit vaccines against HAdV-F40 and HAdV-F41 and provides a novel perspective on the potential of neutralizing antibodies to protect against these two types of HAdV.
引用
收藏
页数:12
相关论文
共 41 条
  • [1] Human adenovirus species B knob proteins as immunogens for inducing cross-neutralizing antibody responses
    Liu, Zhenwei
    Xian, Yuting
    Lan, Jixian
    Zhou, Zhichao
    Li, Xiao
    Zhou, Rong
    Chen, Dehui
    Tian, Xingui
    MSPHERE, 2025, 10 (01)
  • [2] Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice
    Frei, Julia C.
    Wirchnianski, Ariel S.
    Govero, Jennifer
    Vergnolle, Olivia
    Dowd, Kimberly A.
    Pierson, Theodore C.
    Kielian, Margaret
    Girvin, Mark E.
    Diamond, Michael S.
    Lai, Jonathan R.
    JOURNAL OF VIROLOGY, 2018, 92 (18)
  • [3] Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity
    Feng, Ying
    Sun, Xikui
    Ye, Xianmiao
    Feng, Yupeng
    Wang, Jinlin
    Zheng, Xuehua
    Liu, Xinglong
    Yi, Changhua
    Hao, Mingli
    Wang, Qian
    Li, Feng
    Xu, Wei
    Li, Liang
    Li, Chufang
    Zhou, Rong
    Chen, Ling
    Feng, Liqiang
    VIROLOGY, 2018, 518 : 272 - 283
  • [4] Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
    Sampson, Alexander Thomas
    Heeney, Jonathan
    Cantoni, Diego
    Ferrari, Matteo
    Sans, Maria Suau
    George, Charlotte
    Di Genova, Cecilia
    Mayora Neto, Martin
    Einhauser, Sebastian
    Asbach, Benedikt
    Wagner, Ralf
    Baxendale, Helen
    Temperton, Nigel
    Carnell, George
    VIRUSES-BASEL, 2021, 13 (08):
  • [5] Development of a human antibody fragment cross-neutralizing scorpion toxins
    Romero-Moreno, Jose Alberto
    Serrano-Posada, Hugo
    Olamendi-Portugal, Timoteo
    Possani, Lourival D.
    Becerril, Baltazar
    Riano-Umbarila, Lidia
    MOLECULAR IMMUNOLOGY, 2023, 155 : 165 - 174
  • [6] Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections
    Gilchuk, Iuliia
    Gilchuk, Pavlo
    Sapparapu, Gopal
    Lampley, Rebecca
    Singh, Vidisha
    Kose, Nurgun
    Blum, David L.
    Hughes, Laura J.
    Satheshkumar, Panayampalli S.
    Townsend, Michael B.
    Kondas, Ashley V.
    Reed, Zachary
    Weiner, Zachary
    Olson, Victoria A.
    Hammarlund, Erika
    Raue, Hans-Peter
    Slifka, Mark K.
    Slaughter, James C.
    Graham, Barney S.
    Edwards, Kathryn M.
    Eisenberg, Roselyn J.
    Cohen, Gary H.
    Joyce, Sebastian
    Crowe, James E., Jr.
    CELL, 2016, 167 (03) : 684 - +
  • [7] Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses
    Olmedillas, Eduardo
    Cano, Olga
    Martinez, Isidoro
    Luque, Daniel
    Terron, Maria C.
    McLellan, Jason S.
    Melero, Jose A.
    Mas, Vicente
    EMBO MOLECULAR MEDICINE, 2018, 10 (02) : 175 - 187
  • [8] Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12
    Ward, Richard L.
    Kirkwood, Carl D.
    Sander, Donna S.
    Smith, Vicki E.
    Shao, Mingyuan
    Bean, Judy A.
    Sack, David A.
    Bernstein, David I.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (12): : 1729 - 1736
  • [9] Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses
    Dosey, Annie
    Ellis, Daniel
    Boyoglu-Barnum, Seyhan
    Syeda, Hubza
    Saunders, Mason
    Watson, Michael J.
    Kraft, John C.
    Pham, Minh N.
    Guttman, Miklos
    Lee, Kelly K.
    Kanekiyo, Masaru
    King, Neil P.
    CELL REPORTS, 2023, 42 (12):
  • [10] AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees
    Calcedo, Roberto
    Wilson, James M.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2016, 27 (02) : 79 - 82